Selected data models

You must log in to select data models for download or further analysis.

19 Search results.
Relevance Rating New first Old first

Anxiety And Depression Scale (HADS) Ropinirole Restless Legs Syndrom NCT00355641 - Anxiety And Depression Scale

- 9/27/21 - 1 form, 1 itemgroup, 1 item, 1 language
Itemgroup: Hospital anxiety and depression scale
Study part: Anxiety And Depression Scale. A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients with Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Clinicaltrials.gov Identifier: NCT00355641. Phase: phase 3. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/206. Clinical Study ID: 101468/206.

Eligibility Pelvic Pain NCT00895999

- 8/23/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Psychosocial Treatment for Women With Depression and Pain; ODM derived from: https://clinicaltrials.gov/show/NCT00895999

Eligibility Sleep Initiation and Maintenance Disorders NCT00227942

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia; ODM derived from: https://clinicaltrials.gov/show/NCT00227942

Eligibility Epilepsy NCT01941706

- 12/7/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT; ODM derived from: https://clinicaltrials.gov/show/NCT01941706

Eligibility Parkinson's Disease NCT00070941

- 11/21/16 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SAM-e for the Treatment of Depression in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00070941

Eligibility Multiple Sclerosis NCT01079975

- 7/7/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01079975

Eligibility Epilepsy NCT01125241

- 12/7/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01125241

Eligibility Multiple Sclerosis NCT00947232

- 7/6/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI; ODM derived from: https://clinicaltrials.gov/show/NCT00947232

Eligibility Behavioral and Psychological Symptoms in Alzheimer's Disease NCT02103673

- 12/6/18 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia; ODM derived from: https://clinicaltrials.gov/show/NCT02103673

Eligibility Indication for Modification of Patient Cognitive Status NCT01279070

- 4/11/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01279070

visit week 20 physical examination Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 11/3/17 - 1 form, 7 itemgroups, 12 items, 1 language
Itemgroups: administrative data, vital signs, clinical global impression questionnaire, unified parkinson's disease rating scale questionnaire, parkinson's disease sleep scale, Beck Depression Inventory, Epworth Sleepiness Scale
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

visit week 28 physical examination Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 11/3/17 - 1 form, 7 itemgroups, 12 items, 1 language
Itemgroups: administrative data, vital signs, clinical global impression questionnaire, unified parkinson's disease rating scale questionnaire, parkinson's disease sleep scale, Beck Depression Inventory, Epworth Sleepiness Scale
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial